New bladder cancer drug aims to match gold standard in major trial
NCT ID NCT05037279
First seen Apr 12, 2026 · Last updated May 14, 2026 · Updated 4 times
Summary
This Phase 3 trial tests a new treatment called VERITY-BCG for people with intermediate or high-risk non-muscle invasive bladder cancer who have not received BCG therapy before. The study compares VERITY-BCG to the standard BCG treatment (OncoTICE) to see if it works just as well at preventing cancer from coming back within 2 years. About 540 adults will take part, and the goal is to offer a safe, effective alternative for managing this type of bladder cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Site 01
RECRUITINGToronto, Ontario, Canada
Contact
-
Site 02
NOT_YET_RECRUITINGToronto, Ontario, Canada
Contact
-
Site 04
RECRUITINGKingston, Ontario, Canada
Contact
-
Site 05
RECRUITINGVancouver, British Columbia, Canada
Contact
-
Site 08
RECRUITINGToronto, Ontario, Canada
-
Site 10
NOT_YET_RECRUITINGMontreal, Quebec, Canada
Contact
Conditions
Explore the condition pages connected to this study.